Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.

The B cell surface Ig molecule plays an important regulatory role in delivering inductive/tolerogenic signals to the cell. In this paper, the effect of Ag and anti-idiotopic antibodies on the in vitro proliferation and Ig secretion of a B cell tumor was studied. The tumor (BCL1), which had been transfected with the TEPC-15 VH and VL Ig genes, expresses surface Ig and secretes antibody that binds the hapten phosphorylcholine. We found that Ag (C polysaccharide and phosphorylcholine carrier Ag) and two different anti-idiotopic antibodies, in the absence of T cells, all inhibited the proliferation of the T15+ transfectant cell line. The anti-idiotopic antibodies, but not Ag, also inhibited the secretion of T15 Ig by this cell line, suggesting different functional roles for Ag vs anti-Id in the regulation of B cell inactivation. The inhibition of secretion and proliferation appears to be cell cycle phase related. In addition, mouse rIL-4 could override the inhibition of proliferation induced in these studies. These phenomena, demonstrating that binding of surface Ig can result in the transduction of negative growth signals to a B cell tumor, can be viewed as a manifestation of immunologic tolerance. These findings collectively demonstrate that Ag and anti-Id mediate different signals to B cells via interaction with the surface Ig. Because of the monoclonal nature of the T15 transfectant and the anti-idiotypic antibodies, this system can be used to investigate the underlying molecular reactions involved in the B cell response and induction of tolerance.

• Publication year

  1988

• Venue

  Journal of Immunology

• Publication date

  1988-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.141.1.340PMID 3259969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of lymphoid tumors with anti-idiotype antibodies

  2005cited by this paper
• Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.

  1987cited by this paper
• Is tolerance the result of engaging surface Ig of B cells in cycle?

  1987cited by this paper
• Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

  1987cited by this paper
• B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

  1987cited by this paper
• Cell growth cycle block of T cell hybridomas upon activation with antigen

  1987cited by this paper
• Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.

  1987cited by this paper
• Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.

  1987cited by this paper
• Electroporation for the efficient transfection of mammalian cells with DNA.

  1987cited by this paper
• Models and mechanisms for signal transduction in B cells

  1986cited by this paper
• Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.

  1986cited by this paper
• Effects of anti-IgM on mitogen-induced proliferation of human B-lymphocyte malignancies.

  1986cited by this paper
• Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti- mu

  1986cited by this paper
• B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.

  1986cited by this paper
• Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants.

  1985cited by this paper
• B-cell stimulatory factor 1 activates resting B cells.

  1985cited by this paper
• Rapid enumeration of S-phase cells by means of monoclonal antibodies.

  1984cited by this paper
• The generation of diversity in phosphorylcholine-binding antibodies.

  1984cited by this paper
• Idiotype-specific T cell suppression of light chain mRNA expression in MOPC-315 cells is accompanied by a posttranscriptional inhibition of heavy chain expression.

  1984cited by this paper
• Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays

  1983cited by this paper
• Developmental aspects of B-cell repertoire phenotype

  1983cited by this paper
• Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF).

  1983cited by this paper
• B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells.

  1982cited by this paper
• Immunologic regulation of lymphoid tumor cells: model systems for lymphocyte function.

  1982cited by this paper
• T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells

  1982cited by this paper
• Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies.

  1982cited by this paper
• Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

  1982cited by this paper
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2

  1982cited by this paper
• Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

  1981cited by this paper
• Induction of proliferation and differentiation of neoplastic B cells by anti-immunoglobulin and T-cell factors.

  1981cited by this paper
• The effect of anti-immunoglobulin antibodies on the in vitro proliferation and differentiation of normal and neoplastic murineB cells.

  1980cited by this paper
• Induction and Suppression of Polyclonal Antibody Responses by Anti‐Ig Reagents and Antigen‐Nonspecific Helper Factors:

  1980cited by this paper
• Mechanism of neonatal idiotype suppression. I. State of the suppressed B cells.

  1980cited by this paper
• In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.

  1980cited by this paper
• BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor

  1979cited by this paper
• Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.

  1979cited by this paper
• Immunoregulation of Murine Myeloma Cell Growth and Differentiation; A Monoclonal Model of B Cell Differentiation 1

  1979cited by this paper
• Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype

  1979cited by this paper
• Control of B-lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules

  1976cited by this paper
• In vitro tolerance induction of neonatal murine B cells

  1976cited by this paper
• Separate Signals for the Initiation of Proliferation and Differentiation in the B Cell Response to Antigen

  1975cited by this paper
• Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self

  1975cited by this paper
• Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice.

  1975cited by this paper
• Specific unresponsiveness in nude mice given antigen before T cells

  1975cited by this paper
• Myeloma proteins as tumor-specific transplantation antigens.

  1972cited by this paper
• SUPPRESSION OF IDIOTYPIC SPECIFICITIES IN ADULT MICE BY ADMINISTRATION OF ANTIIDIOTYPIC ANTIBODY

  1972cited by this paper
• Affinity labeling of a phosphorylcholine binding mouse myeloma protein.

  1972cited by this paper
• Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

  1972cited by this paper
• Recent observations and concepts in immunological unresponsiveness and autoimmunity.

  1971cited by this paper
• Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

  1970cited by this paper
• Induction of immunological paralysis in two zones of dosage

  1964cited by this paper
• The chemical composition of pneumococcal C-polysaccharide.

  1963cited by this paper
• Specific inhibition of antibody production. I. Protein-over loading paralysis.

  1962cited by this paper

• Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees.

  2009cites this paper
• Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody

  2006cites this paper
• Enhancing Tumor Targeting and Apoptosis Using Noncovalent Antibody Homodimers

  2002cites this paper
• Idiotypes of Human Platelet-Specific Antibodies

  1997cites this paper
• The antigen-specific immunoglobulin G receptor is more sensitive to stimulation than the IgM receptor in transfected B cells.

  1994cites this paper
• Anti‐idiotypic antibodies and regulation of immune responses

  1992cites this paper
• Cryptic T cell epitopes in polymorphic immunoglobulin regions: Evidence for positive repertoire selection during fetal development

  1992cites this paper
• Theoretical and Experimental Insights into Immunology

  1992cites this paper
• The molecular immunology of human platelet proteins.

  1992cites this paper
• Role of Cryptic Self Germline Encoded Ig Epitopes in the Selection of the T cell Repertoire

  1992cites this paper
• Unconjugated Monoclonal Antibodies as Anticancer Agents

  1991cites this paper
• [Monoclonal anti-idiotypic antibodies simulating the biological effects of human alpha-interferons].

  1991cites this paper
• The modulatory effect of anti-idiotypic antibody on hybridoma cells secreting antibody to human myelin basic protein peptide 80-89.

  1990cites this paper
• Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin

  1989cites this paper
• Anti‐Idiotypic B‐Cell Lines from a Patient with Monoclonal Gammopathy of Undetermined Significance

  1989cites this paper
• Immunoglobulin receptor signaling depends on the carboxyl terminus but not the heavy-chain class.

  1989cites this paper
• Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin.

  1989cites this paper
• The Molecular Immunology of Human Platelet Proteins

  year unknowncites this paper